Skip to main content
Equibles

Anthony "A.J." Bergmann

CFO

Capricor Therapeutics, Inc. (CAPR)

Equibles does not estimate personal net worth.

Get an email with a short summary when Capricor Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CAPR alerts

About Anthony "A.J." Bergmann

Anthony "A.J." Bergmann is recorded as CFO at Capricor Therapeutics, Inc. (CAPR). The newest filing on record that lists Anthony "A.J." Bergmann as CFO at Capricor Therapeutics, Inc. (CAPR) is dated April 10, 2026. The proxy statement of Capricor Therapeutics, Inc. reports total compensation of $792,192 for Anthony "A.J." Bergmann in fiscal 2020, including a base salary of $287,500. Disclosed compensation is on record for 3 fiscal years. Anthony "A.J." Bergmann has spoken on 6 earnings calls across 1 company, most recently for Capricor Therapeutics, Inc. on March 12, 2026. Capricor Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Capricor Therapeutics, Inc. includes Linda Marban (CEO and Board Member), Frank Litvack (Chairman and Board Member), Karen G. Krasney (General Counsel) and 7 others.

Anthony "A.J." Bergmann on recent calls

“Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation.”
CFO, Capricor Therapeutics, Inc. Q4 FY2025 Earnings Call ·
“Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation.”
CFO, Capricor Therapeutics, Inc. Q3 FY2025 Earnings Call ·
“Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation.”
CFO, Capricor Therapeutics, Inc. Q2 FY2025 Earnings Call ·
“Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation.”
CFO, Capricor Therapeutics, Inc. Q2 FY2022 Earnings Call ·
“Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation.”
CFO, Capricor Therapeutics, Inc. Q1 FY2022 Earnings Call ·

Affiliation history

Company network

Leadership on record at Capricor Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Capricor Therapeutics, Inc. (CAPR) $287,500 $792,192
2019 Capricor Therapeutics, Inc. (CAPR) $212,500 $252,827
2018 Capricor Therapeutics, Inc. (CAPR) $200,000 $273,700

Recent activity